基因组蛋白质组与生物信息学报(英文版)(Genomics,Proteomics & Bioinformatics)(可网站投稿)

《基因组蛋白质组与生物信息学报(英文版)》(Genomics,Proteomics & Bioinformatics)(双月刊)杂志于2003年创办,经新闻出版总署批准的正规刊物,是由中国科学院主管,中国科学院北京基因组研究所(国家生物信息中心)、中国遗传学会主办的英文版核心期刊。主要刊载:基因组学、蛋白质组学、生物信息学及其相关领域的综述、研究论文、实验技术与方法、研究快讯、研究资源、评论等高质量的稿件。读者对象:生命科学、基础医学、化学、农学、计算机科学领域的科研与教学人员、研究生等,以及数学、物理学等领域对生命科学有兴趣的研究者。现为中国科学引文数据库(CSCD)核心期刊,被美国医学索引(PubMed/MEDLINE)、化学文摘(CA)、ISI Master Journal List、Elsevier书刊目录库(包括荷兰《医学文摘》)、俄罗斯文摘杂志、中国学术期刊文摘、中国期刊全文数据库、万方期刊数据库、维普期刊数据库等国内外收录系统收录全文或摘要。

本刊特点:CSCD核心期刊(2023-2024),高质量科技期刊(T2),SCIE(2024版), 科技核心期刊(2024自然科学),目次收录(维普),知网外文库,第一批认定学术期刊,外文期刊,

基因组蛋白质组与生物信息学报(英文版)(Genomics,Proteomics & Bioinformatics)

期刊基本信息

出版周期:双月刊 级别:核心期刊
主管部门:中国科学院
主办单位:中国科学院北京基因组研究所(国家生物信息中心)、中国遗传学会
编辑部:《基因组蛋白质组与生物信息学报(英文版)》编辑部
中国国内刊号:CN11-4926/Q
国际标准刊号:ISSN 1672-0229;EISSN2210-3244
价格:150元/期
知网复合影响因子:1.471
知网综合影响因子:1.164

杂志社联系方式

地址:北京市朝阳区北辰西路1号院104号楼
邮编:100029
电话:010-84097425
传真:010-84097720
刊内微信公众号:GPBees
杂志邮箱:editor@big.ac.cn
官方网站:http://gpb.big.ac.cn/

杂志征稿投稿要求

《基因组蛋白质组与生物信息学报(英文版)》投稿须知

杂志社官方网站信息

Guide for Authors

Your Paper Your Way

We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.

To find out more, please visit the Preparation section below.

Introduction

Genomics, Proteomics & Bioinformatics publishes papers from all over the world in the fields of genomics, proteomics and bioinformatics. The Journal aims to achieve fast science broadcasting by publishing efficiently. GPB offers Article-in-Press, by which all the accepted manuscripts can be freely accessible online ahead of its printed issue print for fast dissemination. Featured areas and particular interests of GPB include but are not limited to:

•Genomics: functional genomics, evolutionary genomics, comparative genomics, epigenetics, transcriptomics

•Proteomics: protein expression profiling, protein complexes in terms of structure, function, properties and interactions, metabolomics

•Bioinformatics: genome analysis, sequence analysis, genetic and population analysis, phylogenetics, gene expression, database, web server, algorithm, tools and software, with emphasis on large-scale data analysis based on high-throughput sequencing technologies

GPB welcomes submissions from all over the world in the following types:

•High-quality research papers presenting novel data and ideas •Papers describing innovative methods, tools and techniques as well as resources providing primary scientific information to a broad readership •Comprehensive reviews either as full articles or mini-reviews related with author's own research •Commentaries and opinions about new discoveries, scientific policies, and research proposals

Sections:

•Editorials •Essays •Commentaries •Reviews •Research Articles •Letters •Methods •Application Notes •Research Resources

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

CONFLICTS OF INTEREST

A declaration of Conflict of Interest section must be included in the manuscript. A conflict of interest occurs when an individual’s objectivity is potentially compromised by a desire for financial gain, prominence, professional advancement or a successful outcome. GPB Editors strive to ensure that what is published in the Journal is as balanced, objective and evidence-based as possible. Since it can be difficult to distinguish between an actual conflict of interest and a perceived conflict of interest, by declaring no conflict of interest, the Journal requires authors to disclose all and any potential conflicts of interest including:

Section I

The authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Section II

The authors report the following details of affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in the manuscript. Please specify the nature of the conflict on a separate sheet of paper.

By submitting to GPB

By submitting to GPB, the corresponding author certified that all Authors have seen and approved the manuscript being submitted. Authors warrant that the article is the Authors' original work. Authors warrant that the article has not received prior publication and is not under consideration for publication elsewhere. On behalf of all Co-Authors, the corresponding Author shall bear full responsibility for the submission. Authors attest to the fact that all Authors listed on the title page have contributed significantly to the work, have read the manuscript, attest to the validity and legitimacy of the data and its interpretation, and agree to its submission to Genomics, Proteomics & Bioinformatics (GPB). All authors agree that author list is correct in its content and order and that no modification to the author list can be made without the written acceptance of all authors and the formal approval of the Editor-in-Chief. All authors accept that the Editor-in-Chief's decisions over acceptance or rejection or in the event of any breach of the Principles of Ethical Publishing in Genomics, Proteomics & Bioinformatics (GPB) being discovered, of retraction are final.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Author contributions

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing – original draft; Writing – review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example

Authorship Policy

All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, design, analysis, writing, or revision of the manuscript. Furthermore, each author certifies that this material or similar material has not been and will not be submitted to or published in any other publication. The manuscript must include the Author Contribution section, which includes the specific contributions made by each author (list the authors’ initials and contributions). The name of each author must appear at least once in each of the three categories below.

Category 1

Conception and design of study; acquisition of data;analysis and/or interpretation of data.

Category 2

Drafting the manuscript;revising the manuscript critically for important intellectual content.

Category 3

Approval of the version of the manuscript to be published (the names of all authors must be listed).

Changes to Authorship Policy

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of all submitted manuscripts:

Before the manuscript is accepted by journal editor: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Editor from the corresponding author of the submitted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Editor to the corresponding author, who must follow the procedure as described above. Note that: Further process of the manuscript will be halted until authorship has been agreed.

Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Please click to download and fill the Authorship Agreement (https://www.elsevier.com/–data/promis-misc/Authorship Agreement.docx) with all necessary signatures if any changes made on authorship. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

Elsevier supports responsible sharing

Find out how you can share your research published in Elsevier journals.

Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Open access

Please visit our Open Access page for more information.

Elsevier Researcher Academy

Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.

Language (usage and editing services)

Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop. To receive a 10% discount on this service, please use the following code: GPB2003.

Submission

Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

Submit your article

Please submit your article via https://www.editorialmanager.com/gpb/default.aspx.

Peer review

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review.

Article Structure

General manuscript format: Manuscripts must be written in English. Manuscript sections should be presented in the following order: title page, Abstract (less than 200 words), Introduction, Results, Discussion, Conclusions (optional), Materials and methods, Authors' contributions, Competing interests, Acknowledgments, References, followed by Figure legends and Supplementary materials (if any). Please provide each table and figure separately. A manuscript template for research articles is available.

Research paper

Identification of A Novel SBF2 Frameshift Mutation in Charcot-Marie-Tooth Disease Type 4B2 Using Whole-exome Sequencing

Structure samples for other article types:

Minireview

Systems Approaches to Biology and Disease Enable Translational Systems Medicine

Research review

Web Resources for Stem Cell Research

Letter

Complete Sequence of pABTJ2, A Plasmid from Acinetobacter baumannii MDR-TJ, Carrying Many Phage-like Elements

Method article

FunMod: A Cytoscape Plugin for Identifying Functional Modules in Undirected Protein-Protein Networks

Technical note

nuMap: A Web Platform for Accurate Prediction of Nucleosome Positioning

Protocol

Systematic Characterization of Cell Cycle Phase-dependent Protein Dynamics and Pathway Activities by High-content Microscopy-assisted Cell Cycle Phenotyping

Introduction

State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

Results

Results should be clear and concise.

Discussion

This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.

Conclusions

The main conclusions of the study may be presented in a short Conclusions section, which may stand a

Essential Title Page Information

A title page should include: the title, all authors' names and complete affiliations, the corresponding author's complete contact information, a running title (50 characters or less, including spaces), 2-6 key words, and sources of grants or funding supports and personal acknowledgments).

Highlights

Highlights are optional yet highly encouraged for this journal, as they increase the discoverability of your article via search engines. They consist of a short collection of bullet points that capture the novel results of your research as well as new methods that were used during the study (if any). Please have a look at the examples here: example Highlights.

Highlights should be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point).

……

更多详情:

https://www.sciencedirect.com/journal/genomics-proteomics-and-bioinformatics/publish/guide-for-authors

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/11184

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年10月20日 下午4:21
下一篇 2024年10月20日 下午4:21

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息